Top 10 Mid Cap Stocks For 2014

On Monday, small cap molecular diagnostic stock Myriad Genetics, Inc (NASDAQ: MYGN) suddenly sank 9.34% to $23.50 just before the market closed���meaning its probably a good idea to take a closer look at what happened yesterday plus compare the stock�� performance verses small cap peer Sequenom, Inc (NASDAQ: SQNM) and mid cap peer Hologic, Inc (NASDAQ: HOLX).�

What is Myriad Genetics?

Small cap Myriad Genetics is a molecular diagnostic company focused on the discovery and commercialization of transformative tests to assess a person�� risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence. At the moment, Myriad Genetics has nine innovative products, a�390-strong sales force and thirteen pipeline tests in development.

Best Low Price Stocks To Watch For 2015: Brandywine Realty Trust (BDN)

Brandywine Realty Trust is a publically owned real estate investment trust. The firm invests in real estate markets of the United States. It makes investments in office, mixed-use, and industrial properties. Brandywine Realty Trust was founded in 1985 and is based in Radnor, Pennsylvania with additional offices in Mount Laurel, New Jersey; Richmond, Virginia; Dallas, Texas; Falls Church, Virginia; Oakland, California; Austin, Texas, and Carlsbad, California.

Advisors' Opinion:

• [By Jonas Elmerraji]

   

   

  You don't have to be an expert technical trader to figure out what's going on in shares of Brandywine Realty Trust (BDN) -- this chart pattern is about as simple as it gets. Brandywine has been bouncing higher in a well-defined uptrending channel since last summer, giving traders a high-probability range to buy the dips.

   

  More specifically, the ideal buying opportunity has come up for BDN bulls every time this stock has bounced off of trendline support along the bottom of the channel. Waiting for a meaningful bounce off of support is crucial for two big reasons: It's the spot where shares have the furthest to move up before they hit resistance, and it's also the spot where the risk is the least (because shares have the least room to move lower before you know you're wrong).

   

  Remember, all trend lines do eventually break, but by actually waiting for the bounce to happen first, you're ensuring BDN can actually still catch a bid along that line before you put your money on shares. At current levels, BDN pays out a whopping 4% dividend yield.

   

Top 10 Mid Cap Stocks For 2014: OraSure Technologies Inc.(OSUR)

OraSure Technologies, Inc. develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States and internationally. It also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. The company offers OraQuick ADVANCE HIV-1/2, a point-of-care qualitative test for antibodies to the human immunodeficiency virus type 1 and type 2; OraQuick HCV, a point-of-care qualitative test for antibodies to the hepatitis C virus; OraSure QuickFlu Rapid Flu A&B Test, a point-of-care qualitative test for antibodies to influenza Types A and B, including H1N1 infections; OraSure, an oral fluid collection device for the detection of antibodies to HIV-1 in an oral fluid sample in a laboratory setting; and Intercept, an oral fluid collection device for oral fluid drugs of abuse testing in a laboratory setting. In addition, it provides MICRO-PLATE DOA Assays that are used to detect the drugs in an oral fluid sample collected with intercept device; cryosurgical freezing systems for the removal of warts and other benign skin lesions; and cryosurgical systems for the removal of common and plantar warts. Further, OraSure Technologies sells immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot HIV-1 confirmatory test for confirming positive HIV-1 test results obtained from the use of OraSure collection device; and Q.E.D., a point-of-care saliva alcohol test. The company sells its products through direct sales, strategic collaborations, and distributors to clinical laboratories, hospitals, clinics, community-based and other public health organizations, distributors, government agencies, physicians? offices, and commercial and industrial entities. It has collaboration agreement with Merck & Co. Inc. OraSure Technologies, Inc. was founded in 1979 and is based in Beth lehem, Pennsylvania.

Advisors' Opinion:

• [By Sam Collins]

  OraSure Technologies (OSUR) — This small-cap company develops, manufactures and markets oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies.

Top 10 Mid Cap Stocks For 2014: Roadrunner Transportation Systems Inc (RRTS)

Roadrunner Transportation Systems, Inc. operates as a non-asset based transportation and logistics service company. It provides a suite of solutions, including customized and expedited less-than-truckload, truckload brokerage, transportation management solutions, intermodal solutions, and domestic and international air services. The company is headquartered in Cudahy, Wisconsin.

Advisors' Opinion:

• [By Seth Jayson]

  Margins matter. The more Roadrunner Transportation Systems (NYSE: RRTS  ) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. Healthy margins often separate pretenders from the best stocks in the market. That's why we check up on margins at least once a quarter in this series. I'm looking for the absolute numbers, so I can compare them to current and potential competitors, and any trend that may tell me how strong Roadrunner Transportation Systems's competitive position could be.

• [By Seth Jayson]

  Roadrunner Transportation Systems (NYSE: RRTS  ) reported earnings on May 1. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended March 31 (Q1), Roadrunner Transportation Systems beat slightly on revenues and beat expectations on earnings per share.

Top 10 Mid Cap Stocks For 2014: Coleman Cable Inc.(CCIX)

Coleman Cable, Inc. designs, develops, manufactures, and supplies electrical wire and cable products for consumer, commercial, and industrial applications primarily in the United States and Canada. It provides industrial wire and cable products, including portable cords, machine tool wiring, building wires, welding, mining, pump, control, stage/lighting, diesel/locomotive, instrumentation, tray, thermocouple, high temperature, and metal clad cables, as well as other power cord products under the Royal, Seoprene, Copperfield, Continental, Triangle, and Corra/Clad brand names. The company also offers assembled wire and cable products comprising various types of extension cords, ground fault circuit interrupters, portable lighting, retractable reels, holiday items, solar lighting, recreational vehicle cords and adapters, and surge and strip products, as well as booster cables, battery cables, and battery accessories for the automotive aftermarket. It provides assembled wire a nd cable products under the brand names of Woods, Moonrays, Polar Solar, Yellow Jacket, American Contractor, Road Power, Power Station, Booster-in-a-Bag, TRC, Shock Shield, Electra Shield, Fire Shield, and Designers Edge, as well as privately-labeled brands. In addition, the company offers electronic wire products, such as telephone, data, security, coaxial, industrial automation, instrumentation, twinaxial, fire alarm, plenum, and home automation cables that connect devices under the Signal, Plencote, Soundsational, and Clear Signal brand names. Further, it provides fabricated bare wire products consisting of stranded, bunched, and single-end copper, copper-clad steel, and various copper alloy wires under the brand name of Copperfield. The company sells its products to specialty distributors, retailers, and original equipment manufacturers. Coleman Cable, Inc. was founded in 1970 and is based in Waukegan, Illinois.

Advisors' Opinion:

• [By Damian Illia]

  On Jan. 17, Mario Gabelli (Trades, Portfolio), the chairman and chief executive officer of GAMCO Investors Inc., bought Coleman Cable Inc. (CCIX) at an average price of $23.26 and currently holds 729,100 shares of the stock. He is betting in favor of the Electrical Components & Equipment sub-industry.

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Coleman Cable (Nasdaq: CCIX  ) , whose recent revenue and earnings are plotted below.

Top 10 Mid Cap Stocks For 2014: Bovis Homes Group PLC (BVS)

Bovis Homes Group PLC is a builder of traditional homes in England and Wales. The Company�� business involves the designing, building and selling of new homes for both private and public sector customers. The Company delivers projects such as Land acquisition, Planning, Legal, Design, Surveying, Engineering, Purchasing, Construction, Sales and marketing, Public relations and Customer service. Advisors' Opinion:

• [By Inyoung Hwang]

  Bovis Homes Group Plc (BVS) climbed 4 percent to 790 pence. Liberum Capital Ltd. raised its rating on the housebuilder to buy from hold. Persimmon Plc (PSN), the U.K.�� largest residential property developer, gained 2.5 percent to 1,255 pence.

Top 10 Mid Cap Stocks For 2014: Trans World Entertainment Corp.(TWMC)

Trans World Entertainment Corporation, through its subsidiaries, operates as a specialty retailer of entertainment software products, including music, video, video games, and other related products through its retail stores and e-commerce sites in the United States. The company?s other related products include electronics, accessories, and trend items. As of January 29, 2011, it operated 376 mall-based stores under the For Your Entertainment (f.y.e.), Suncoast Motion Pictures, and Saturday Matinee brand names in regional shopping malls; 84 freestanding stores under the f.y.e. brand name; and 3 retail Websites, including fye.com, wherehouse.com, and secondspin.com. The company operates retail stores in the United States, the District of Columbia, the Commonwealth of Puerto Rico, and the U.S. Virgin Islands. Trans World Entertainment Corporation was founded in 1972 and is headquartered in Albany, New York.

Advisors' Opinion:

• [By Tim Melvin]

  The safe and cheap undervalued stocks will go right up, but your chances of being destroyed when the party is over are diminished. Stocks like Richardson Electronics (RELL) and Transworld Entertainment (TWMC) have the ability to go up as the market bubbles higher but their asset value will act as sort of a floor in a decline.

Top 10 Mid Cap Stocks For 2014: Neogenomics Inc (NEO)

NeoGenomics, Inc. (NeoGenomics) operates a network of cancer-focused testing laboratories. The Company offers testing services, including Cytogenetics testing, which is the study of normal and abnormal chromosomes and their relationship to disease; fluorescence in-situ hybridization (FISH) testing, which is a branch of cancer genetics that focuses on detecting and locating the presence or absence of specific deoxyribonucleic acid (DNA) sequences and genes on chromosomes; flow cytometry testing, which is a way to measure the characteristics of cell populations; immunohistochemistry (IHC) testing, this is the process of identifying cell proteins in a tissue section utilizing the principle of antibodies binding specifically to antigens, and molecular testing, which is a cancer diagnostic tool focusing on the analysis of DNA and ribonucleic acid (RNA), as well as the structure and function of genes at a molecular level.

The cancer testing services, that the Company offers to community-based pathologists are designed to be a natural extension of, and complementary to, the services that they perform within their own practices. In areas where the Company does not provide services to community-based pathology practices, it may directly serve oncology, dermatology, urology and other clinician practices that prefer to have a direct relationship with a laboratory for cancer-related genetic and molecular testing services. NeoGenomics services these types of clients with a global service offering where it performs both the technical and professional components of the tests ordered.

The Company offers tech-only flow cytometry and immunohistochemistry testing services. These types of testing services generally allow the professional interpretation component of a test to be billed separately from the technical component. Its NeoFISH, NeoFLOW and other tech-only service offerings allow properly trained and credentialed community-based pathologists to extend their own practices by performing ! professional interpretations services.

The Company's tech-only services are designed to give pathologists the option to choose, on a case by case basis, whether they want to order just the technical information and images relating to a specific test so they can perform the professional interpretation, or order global services and receive a test report, which includes a NeoGenomics Pathologist�� interpretation of the test results.

The Company also offers a set of global services to meet the needs of those clients who are not credentialed and trained in interpreting genetic tests and who are looking for specialists to interpret the testing results for them. In its global service offerings, its lab performs the technical component of the tests and its doctor of medicine (M.D.s) and doctor of philosophy (Ph.D) s to provide the interpretation services. Its genetic pathology solutions (GPS) report summarizes all relevant case data from its global services on one summary report.

The Company competes with General Electric Healthcare Services and Novartis, A.G.

Advisors' Opinion:

• [By John Udovich]

  One way or the other, Merrimack Pharmaceuticals Inc (NASDAQ: MACK), Covidien plc (NYSE: COV), NeoGenomics, Inc (NASDAQ: NEO) and�CollabRx Inc (NASDAQ: CLRX) are targeting Barrett's Esophagus�or�esophageal cancer�(the former often leads to the latter) ��a form of cancer that may not be on the top of your list of cancers but is nevertheless on the rise. Approximately 3 million Americans suffer from Barrett's Esophagus, �a condition that�develops as a result of chronic injury from gastroesophageal reflux disease (GERD) where the�normal esophageal lining is replaced with abnormal cells (known as Barrett�� tissue), putting patients at greater risk of developing cancer of the esophagus. And although less than 1% of these patients develop cancer each year, esophageal carcinoma is frequently not detected until later stages, at which point therapy options are limited, extremely invasive, and often ineffective.�This means that�early detection is important�along with�regular surveillance is recommended.�